GMAB Dividend History & Analysis | N/A Yield
GMAB has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| JBIO | 280 M | 24.0% | 0.31% |
| ABBV | 400,779 M | 2.88% | 9.50% |
| GILD | 150,708 M | 2.60% | 6.37% |
| AMGN | 159,253 M | 3.22% | 4.89% |
| HLN | 40,587 M | 1.90% | 2.46% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| GRFS | 8,431 M | 127% | 60.7% |
| HLN | 40,587 M | 51.0% | 100% |
| AMGN | 159,253 M | 8.90% | 100% |
| ABBV | 400,779 M | 7.06% | 100% |
| GILD | 150,708 M | 3.16% | 100% |
Similar Stocks with Attractive Dividends - Compare GMAB Dividends with its Peer-Group
2.88% Yield
3.22% Yield
2.60% Yield
1.90% Yield
GMAB Dividend History: as of October 2025
No dividends paid yet.GMAB Dividend FAQ
Genmab A/S (NASDAQ:GMAB) is a Denmark-based biotech firm that creates antibody-based therapeutics for oncology and a range of other diseases. Its commercial portfolio includes EPKINLY and TEPKINLY for relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma, and Tivdak for metastatic cervical cancer after chemotherapy failure. The pipeline spans multiple modalities-bispecific antibodies (e.g., epcoritamab), antibody-drug conjugates (e.g., tisotumab vedotin), and novel immune-modulating agents (e.g., Mim8 for hemophilia A)-targeting hematologic malignancies, solid tumors, and non-oncology indications such as multiple sclerosis and thyroid eye disease.
What is the Dividend Yield of GMAB?
As of October 2025, GMAB`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 29.89.Does GMAB pay a dividend?
As of October 2025 GMAB does not pay a dividend.How often does GMAB pay dividends?
Over the last 12 months, GMAB has issued dividend payments.Will GMAB pay dividends in 2025?
The next Ex-Dividend date for Genmab AS (GMAB) is currently unknown.What is the next Ex-Dividend Date for GMAB?
The next Ex-Dividend date for Genmab AS (GMAB) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of GMAB?
GMAB's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of GMAB?
GMAB's 5-Year Yield on Cost is -%. If you bought GMAB's shares at 34.97 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of GMAB?
GMAB Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does GMAB have a good Dividend Yield?
GMAB`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of GMAB?
The Dividend Payout Ratio of GMAB is unknown.What is the Dividend Rating of GMAB?
GMAB`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-17 04:40